Skip to main content

Table 6 Comparison of epidemiologic cutoff values (ECV) of A. flavus with Etest MICs obtained in the present study by Etest

From: Molecular identification and antifungal susceptibility profile of Aspergillus flavus isolates recovered from clinical specimens in Kuwait

Drug

ECV (μg/μl)*

% of isolates ≤ ECV

 
  

RPMI 1640

MH-GMB

Voriconazole

1.0 (98.1%)

92 (100 %)

92 (100 %)

Posaconazole

0.25 (95 %)

91 (98.9 %)

86 (93.5 %)

Caspofungin

0.25 (95%)

92 (100 %)

92 (100%)

Amphotericin B

4.00 (99%)

92 (100%)

89 (96.7%)

  1. *Espinel-Ingroff et al. [1416].
  2. Note: Epidemiologic cutoff of wild-type strains of A. flavus are not available for micafungin and anidulafungin.